Novartis India Limited at its board meeting held on November 9, 2022, announced Ms. Monaz Noble resigned from her position of Non-Executive and Non-Independent Director of the Company to explore new opportunities to broaden her horizons with effect from the close of business hours of November 21, 2022. Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the appointment of Ms. Shilpa Joshi as additional Director of the Company with effect from November 22, 2022; and Whole-Time Director (designated as 'Whole-Time Director and Chief Financial Officer') of the company for a period of 5 years with effect from November 22, 2022 upto November 21, 2027 subject to the approval of the Members of the Company.